AN2 Therapeutics grants inducement equity awards to two new employees
ANTX•AN2 Therapeutics granted two new employees options covering 10,565 shares and 5,283 restricted stock units under its 2026 Employment Inducement Award Plan.
ANTX•ANTX•ANTX•AN2 Therapeutics granted two new employees options covering 10,565 shares and 5,283 restricted stock units under its 2026 Employment Inducement Award Plan.
The grants were made on October 19, 2026. The options vest 25% on the first anniversary of the vesting commencement date, then in monthly installments of 1/48th on the same day of each month. The restricted stock units vest annually over four years, subject to continuous service.
